CN1526415A - Medicine composition for treating cold - Google Patents
Medicine composition for treating cold Download PDFInfo
- Publication number
- CN1526415A CN1526415A CNA03106955XA CN03106955A CN1526415A CN 1526415 A CN1526415 A CN 1526415A CN A03106955X A CNA03106955X A CN A03106955XA CN 03106955 A CN03106955 A CN 03106955A CN 1526415 A CN1526415 A CN 1526415A
- Authority
- CN
- China
- Prior art keywords
- medicine composition
- cold
- rhizoma
- medicine
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to one kind of medicine composition made of Chinese herbal medicine materials for treating cold. The medicine composition is prepared with sweet wormwood, astragalus root, camellia and notopterygium root. The toxicity test proves no toxic side effect of the medicine composition; the pharmacological research shows its obvious effects of resisting influenza virus, bacteriostasis, clearing away heat, relieving pain, diminishing inflammation, relieving cough, etc. and clinical application proves its cold preventing and treating function.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of flu, particularly relate to the pharmaceutical composition that a kind of treatment that with the vegetable Chinese herbal medicine is raw material is made is caught a cold.
Background technology
Flu is a kind of common, frequently-occurring disease, we can say, as long as crowd's place is arranged, just can catch a cold inevitably, and easily popular, seriously threatening human beings'health.Yet, not fully up to expectations with existing chemical drugs treatment flu, generally can only play some effects of improving symptom, and side effect is in various degree arranged.Therefore, the research and development Chinese patent medicine prevents, treats flu its only road part.
Summary of the invention
Purpose of the present invention is intended to provide a kind of combination of oral medication for the treatment of flu.
The pharmaceutical composition of treatment flu of the present invention is the medicament of being made by the following weight proportion raw material: Herba Artemisiae Annuae 75-225, Radix Astragali 50-150, hill tea 40-120, Rhizoma Et Radix Notopterygii 40-120.
In above-mentioned materials of weight proportions, also can add Bulbus Lilii 50-150, wherein the also available Herba Schizonepetae of Rhizoma Et Radix Notopterygii substitutes.
Herba Artemisiae Annuae of the present invention is the dry aerial parts of feverfew Herba Artemisiae annuae Artemisia annua L..Be stated from P of Chinese Pharmacopoeia version in 2000
158Bodinier elsholtzia herb is the herb of labiate East Perillae Elsholtziabodinieri Van ' t.Be stated from Chinese medicine voluminous dictionary P
489The Radix Astragali is the dry root of leguminous plant Radix Astagali Astragalusmembranaceus (Fisch.) Bge.var.mongholicus (Bge.) Hsiao or Radix Astragali Astragalusmembranaceus (Fisch.) Bge..Be stated from P of version Chinese Pharmacopoeia in 2000
249Bulbus Lilii is the dry meat scale leaf of liliaceous plant tiger lily Lilium lancifolium Thunb., Bulbus Lilii Lilium brownii F.E.Brownvar.viridulum Baker or Lilium tenuifolium Lilium pumilum DC.Be stated from P of version Chinese Pharmacopoeia in 2000
100Rhizoma Et Radix Notopterygii is dry rhizome and the root of samphire Rhizoma Et Radix Notopterygii Notopterygium incisum Ting exH.T.Chang or Radix et Rhizoma Notopterygii Notopterygium forbesii Boiss.Be stated from P of version Chinese Pharmacopoeia in 2000
144Herba Schizonepetae is the dry aerial parts of labiate Herba Schizonepetae Schizonepeta tenuifolia Briq..Be stated from P of version Chinese Pharmacopoeia in 2000
186
The present invention is a principal agent with little Flos Camelliae Japonicae, plays to disperse to induce sweat the effect of clearing away heat-damp and promoting diuresis, treatment headache due to invasion of exogenous pathogens, throat pain, snivel etc.Herba Artemisiae Annuae, Rhizoma Et Radix Notopterygii are accessory drugs, and Herba Artemisiae Annuae can clearing away the hectic fever, bring down a fever; The Rhizoma Et Radix Notopterygii cold expelling dispels the wind, and removing damp and stopping pain can be assisted hill tea treatment headache, heating; Assistant is with Bulbus Lilii nourishing YIN and moistening the lung, preventing phlegm from forming and stopping coughing.The Radix Astragali is a messenger drug, Gan Wen, and invigorating QI to consolidate the body surface resistance with the immunocompetence of further raising body, recovers its human body as early as possible.
Medicament of the present invention is a said dosage form on the pharmaceutics.Can be the capsule made through conventional technology of raw material of the present invention and corresponding medicinal adjuvant, tablet, electuary, spray etc.
Pharmaceutical composition of the present invention has no side effect through the toxicity test proof; Through pharmacodynamic study and clinical trial, have the effect of significant treatment headache, pharyngalgia, nasal obstruction, cough, be used for contact flu colony, prevention or treatment have some inkling of a cold.
Pharmacological evaluation is as follows:
The resisiting influenza virus experiment: experiment in vitro adopts double-blind method to carry out, and experimental result shows that hill tea cold medicine extractum has stronger resisiting influenza virus effect.
Bacteriostatic test: the experiment in vitro result shows that hill tea cold medicine extractum all has bacteriostasis to streptococcus pneumoniae, beta hemolysis streptococcus, Sarcina lutea, staphylococcus aureus, staphylococcus epidermidis, Salmonella typhimurium etc.
Refrigeration function: the oral hill tea of mice cold medicine, the result has obvious reduction effect to fervescence due to the 2,4 dinitrophenyl hydrazine.
Analgesic activity: the oral hill tea of mice cold medicine, the result has obvious inhibitory action to turning round body pain due to the HAC.
Antiinflammatory action: the oral hill tea of mice cold medicine, xylol causes the auricular concha inflammation as a result obvious inhibitory action.
Antitussive effect: the oral hill tea of mice cold medicine, the result causes sulfur dioxide and has coughed obvious antitussive effect.
Acute toxicity test:
The oral hill tea of mice cold medicine, no overt toxicity reaction takes place.
The specific embodiment
Embodiment 1:
By the following prescription material of getting it filled: Herba Artemisiae Annuae 100, the Radix Astragali 80, hill tea 70, Rhizoma Et Radix Notopterygii 80, Bulbus Lilii 80, its whole pulverize separately are become coarse powder, get Herba Artemisiae Annuae, Rhizoma Et Radix Notopterygii, little Flos Camelliae Japonicae three flavor medical materials and extract volatile oil through vapor distillation.The medicinal residues and the Radix Astragali, Bulbus Lilii add the certain proportion alcohol reflux three times, merge extractive liquid,, filter, are condensed into extractum.Add an amount of pharmaceutic adjuvant, volatile oil, make oral formulations such as granule, tablet, capsule.
Embodiment 2:
Get Herba Artemisiae Annuae 180, the Radix Astragali 120, hill tea 100, Rhizoma Et Radix Notopterygii 100, make oral formulations according to the method described above.
Embodiment 3:
Get Herba Artemisiae Annuae 150, the Radix Astragali 100, hill tea 60, Herba Schizonepetae 80, Bulbus Lilii 100, make oral formulations according to the method described above.
Claims (2)
- The pharmaceutical composition of 1, treatment flu is characterized in that it being the medicament of being made by the following weight proportion raw material: Herba Artemisiae Annuae 75-225, Radix Astragali 50-150, hill tea 40-120 Rhizoma Et Radix Notopterygii 40-120.
- 2,, it is characterized in that containing the Bulbus Lilii 50-150 of weight proportion according to the described pharmaceutical composition of claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03106955 CN1205978C (en) | 2003-03-04 | 2003-03-04 | Medicine composition for treating cold |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03106955 CN1205978C (en) | 2003-03-04 | 2003-03-04 | Medicine composition for treating cold |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1526415A true CN1526415A (en) | 2004-09-08 |
| CN1205978C CN1205978C (en) | 2005-06-15 |
Family
ID=34282848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03106955 Expired - Fee Related CN1205978C (en) | 2003-03-04 | 2003-03-04 | Medicine composition for treating cold |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1205978C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524284A (en) * | 2014-12-23 | 2015-04-22 | 顾�卓 | Medicine for preventing and treating flu |
-
2003
- 2003-03-04 CN CN 03106955 patent/CN1205978C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524284A (en) * | 2014-12-23 | 2015-04-22 | 顾�卓 | Medicine for preventing and treating flu |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1205978C (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Silveira et al. | COVID-19: is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? | |
| Hartanti et al. | The potential roles of jamu for COVID-19: a learn from the traditional Chinese medicine | |
| US7198804B2 (en) | Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases | |
| Kumar et al. | Indian medicinal plants used for treatment of rheumatoid arthritis | |
| CN105535439A (en) | Traditional Chinese medicinal composition for treating pharyngitis and preparation method thereof | |
| CN101569712B (en) | Chinese traditional medicine composition for treating cold | |
| Su et al. | A comprehensive review of research progress on the genus Arisaema: Botany, uses, phytochemistry, pharmacology, toxicity and pharmacokinetics | |
| CN1150018C (en) | Medicine for treating tachy-arrhythmia | |
| CN101366858A (en) | Preparation method of medicament for clearing heat, discharging fire, dispelling wind and relieving pain | |
| CN101537160B (en) | Health product for toxicant elimination and beauty maintenance | |
| CN1205978C (en) | Medicine composition for treating cold | |
| CN1618454A (en) | Medicinal composition for treating acne and beauty-care, and its prepn. method | |
| CN1903299A (en) | Traditional Chinese medicine decoction for treating-ache and expelling atagnate | |
| CN1255170C (en) | Cough-relieving bagged tea and its prepn | |
| CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
| Alaghawani et al. | Study the hypoglycemic effect of Crataegus laevigata in diabetic rats | |
| CN1170559C (en) | Capsule for removing heat from liver and detoxicating and its preparing process | |
| CN1191086C (en) | Medicine for treating cold in summer and autumn | |
| Chen et al. | “Qingfei Paidu Decoction”—A Possible Choice of Phytotherapy for Severe Acute Respiratory Infection Caused by Coronavirus Disease-19 | |
| CN101057949A (en) | Traditional Chinese medicine one-step preparation for treating coronary heart disease | |
| CN1291729C (en) | Antiviral Chinese medicine prepn of Hypericum perforatumand its prepn process | |
| CN102145090B (en) | Traditional Chinese medicinal composition for eliminating wind and relieving heat and preparation method thereof | |
| CN101837107A (en) | Traditional Chinese medicine for curing acute and chronic cholecystitis, biliary tract infection, gall-stone, and biliary tract postoperative syndromes | |
| Mungamuri et al. | Role of Dietary Supplementation of Natural Products in the Prevention and Treatment of Liver Diseases | |
| CN1334114A (en) | Chinese medicine for treating mastoplasia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |